112 related articles for article (PubMed ID: 152143)
1. Phase I study with neocarzinostatin: tolerance to two hour infusion and continuous infusion.
Ohnuma T; Nogeire C; Cuttner J; Holland JF
Cancer; 1978 Oct; 42(4):1670-9. PubMed ID: 152143
[TBL] [Abstract][Full Text] [Related]
2. Neocarzinostatin: a phase I clinical trial with five-day intermittent and continuous infusions.
McKelvey EM; Burgess MA; McCredie KB; Murphy WK; Bodey GP
Cancer; 1979 Oct; 44(4):1182-8. PubMed ID: 159119
[TBL] [Abstract][Full Text] [Related]
3. Phase I study of neocarzinostatin in children with cancer.
Rivera G; Howarth C; Aur RJ; Pratt CB
Cancer Treat Rep; 1978 Dec; 62(12):2105-7. PubMed ID: 156067
[TBL] [Abstract][Full Text] [Related]
4. Treatment of acute nonlymphocytic leukemia with neocarzinostatin.
Griffin TW; Lister TA; Rybak ME; Rosenthal DS; Canellos GP; Woodruff R; Oliver KT
Cancer Treat Rep; 1979; 63(11-12):1853-6. PubMed ID: 160835
[TBL] [Abstract][Full Text] [Related]
5. Neocarzinostatin: report of a phase II clinical trial.
McKelvey EM; Murphy W; Zander A; Bodey GP
Cancer Treat Rep; 1981; 65(7-8):699-701. PubMed ID: 6454486
[TBL] [Abstract][Full Text] [Related]
6. Phase I and preliminary phase II study of neocarzinostatin.
Griffin TW; Comis RL; Lokich JJ; Blum RH; Canellos GP
Cancer Treat Rep; 1978 Dec; 62(12):2019-25. PubMed ID: 221112
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of neocarzinostatin in patients with bladder and prostatic cancer: toxicity of a five-day iv bolus schedule.
Natale RB; Yagoda A; Watson RC; Stover DE
Cancer; 1980 Jun; 45(11):2836-42. PubMed ID: 6445776
[TBL] [Abstract][Full Text] [Related]
8. Initial clinical study with pyrazofurin.
Ohnuma T; Holland JF
Cancer Treat Rep; 1977; 61(3):389-94. PubMed ID: 872139
[TBL] [Abstract][Full Text] [Related]
9. [Reinduction chemotherapy of acute leukemia with neocarzinostatin and other conventional antileukemic agents (author's transl)].
Nagao T; Kammura O; Nozaki H; Takahashi Y; Niiya K
Rinsho Ketsueki; 1976 Aug; 17(8):838-43. PubMed ID: 144198
[No Abstract] [Full Text] [Related]
10. Initial clinical study with vindesine: tolerance to weekly iv bolus and 24-hour infusion.
Ohnuma T; Greenspan EM; Holland JF
Cancer Treat Rep; 1980 Jan; 64(1):25-30. PubMed ID: 6929728
[TBL] [Abstract][Full Text] [Related]
11. Phase I study of neocarzinostatin in patients with acute leukemia.
Van Echo DA; Wiernik PH
Cancer Treat Rep; 1978 Sep; 62(9):1363-5. PubMed ID: 150945
[No Abstract] [Full Text] [Related]
12. A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.
Early AP; Preisler HD; Slocum H; Rustum YM
Cancer Res; 1982 Apr; 42(4):1587-94. PubMed ID: 6949642
[TBL] [Abstract][Full Text] [Related]
13. Phase I and pharmacokinetic study of the ribonucleotide reductase inhibitor, 3-aminopyridine-2-carboxaldehyde thiosemicarbazone, administered by 96-hour intravenous continuous infusion.
Wadler S; Makower D; Clairmont C; Lambert P; Fehn K; Sznol M
J Clin Oncol; 2004 May; 22(9):1553-63. PubMed ID: 15117978
[TBL] [Abstract][Full Text] [Related]
14. Phase I study of NKT-01.
Tamura K; Niitani H; Oguro M; Ohno R; Sanpi K; Majima H; Masaoka T; Kimura I; Inagaki J; Suzuoki Y
Cancer Chemother Pharmacol; 1995; 36(3):189-94. PubMed ID: 7781137
[TBL] [Abstract][Full Text] [Related]
15. Zinostatin (neocarzinostatin).
Issell BF; Prestayko AW; Comis RL; Crooke ST
Cancer Treat Rev; 1979 Dec; 6(4):239-49. PubMed ID: 161199
[No Abstract] [Full Text] [Related]
16. Mitoxantrone in the treatment of relapsed and refractory acute leukemia.
Moore JO; Olsen GA
Semin Oncol; 1984 Sep; 11(3 Suppl 1):41-6. PubMed ID: 6385265
[TBL] [Abstract][Full Text] [Related]
17. Phase 1 study of carboplatin in patients with advanced cancer, intermittent intravenous bolus, and 24-hour infusion.
Leyvraz S; Ohnuma T; Lassus M; Holland JF
J Clin Oncol; 1985 Oct; 3(10):1385-92. PubMed ID: 3900302
[TBL] [Abstract][Full Text] [Related]
18. Technique for preclinical evaluation of continuous infusion chemotherapy with the use of WF rat acute myelogenous leukemia.
Ensminger WD; Greenberger JS; Egan EM; Muse MB; Moloney WC
J Natl Cancer Inst; 1979 May; 62(5):1265-8. PubMed ID: 155752
[TBL] [Abstract][Full Text] [Related]
19. [A case of complete remission following recurrent relapses 12 years after onset of acute myelocytic leukemia. Response to protocol including neocarzinostatin].
Odajima H; Iwatake K; Baba M; Ode S; Kawai H; Matsui T
Gan To Kagaku Ryoho; 1988 Jan; 15(1):167-70. PubMed ID: 2962538
[TBL] [Abstract][Full Text] [Related]
20. Phase I study of VP-16-213 (Etoposide) administered as a continuous 5-day infusion.
Lokich J; Corkery J
Cancer Treat Rep; 1981; 65(9-10):887-9. PubMed ID: 7273024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
